|
|
|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | ||
| Transplants | 2,954 | 3,064 | 3,440 | 3,652 | 3,931 | 4,077 | 4,185 | 4,503 | 4,715 | 4,962 | |
| Tx With Follow-up Immunosuppression Info | 2,163 | 2,308 | 2,635 | 2,852 | 3,115 | 3,153 | 3,312 | 3,649 | 3,714 | 3,947 | |
| Corticosteroids | Category Usage | 93.2% | 93.0% | 97.8% | 98.3% | 96.7% | 95.2% | 94.8% | 92.7% | 90.8% | 90.2% |
| Prednisone | 92.3% | 92.2% | 93.6% | 90.7% | 87.8% | 89.6% | 91.0% | 87.6% | 85.1% | 84.5% | |
| Methylprednisolone | 1.0% | 0.9% | 4.9% | 8.7% | 9.6% | 7.7% | 5.0% | 8.5% | 13.6% | 10.1% | |
| Cyclosporine | Category Usage | 77.0% | 79.2% | 80.0% | 66.2% | 50.2% | 42.5% | 39.7% | 33.6% | 31.1% | 24.2% |
| Cyclosporin | 77.0% | 79.1% | 79.8% | 62.2% | 25.8% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | |
| Sandimmmune | 0.6% | 1.0% | 2.1% | 5.6% | 17.0% | 9.0% | 5.9% | 7.2% | 7.0% | 5.7% | |
| Neoral | 0.0% | 0.1% | 0.2% | 3.0% | 28.5% | 37.3% | 36.4% | 29.5% | 27.3% | 20.9% | |
| Gengraf | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.0% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.2% | |
| Tacrolimus | Category Usage | 27.0% | 23.8% | 25.5% | 43.3% | 56.9% | 64.1% | 66.2% | 73.1% | 77.4% | 83.5% |
| FK506 | 27.0% | 23.8% | 25.5% | 43.3% | 56.9% | 64.1% | 66.2% | 73.1% | 77.4% | 83.5% | |
| Antimetabolites | Category Usage | 55.7% | 56.2% | 57.7% | 48.5% | 43.5% | 44.2% | 43.7% | 39.3% | 49.1% | 51.7% |
| Azathioprine | 55.4% | 56.2% | 57.2% | 47.2% | 33.5% | 20.8% | 17.8% | 10.2% | 8.2% | 5.9% | |
| Mycophenolate mofetil | 0.6% | 0.0% | 0.6% | 1.7% | 12.2% | 24.7% | 29.6% | 31.2% | 42.8% | 47.4% | |
| Other | Category Usage | 0.3% | 0.4% | 0.5% | 0.4% | 0.4% | 0.3% | 0.4% | 1.3% | 3.2% | 15.9% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.2% | 2.9% | 15.5% | |
| Cytoxan | 0.3% | 0.4% | 0.5% | 0.4% | 0.4% | 0.3% | 0.4% | 0.1% | 0.2% | 0.5% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.